Registered number
08131565
Endocrine1 Ltd
Filleted Accounts
31 July 2023
Endocrine1 Ltd
Registered number: 08131565
Balance Sheet
as at 31 July 2023
Notes 2023 2022
£ £
Current assets
Debtors 4 53,641 42,409
Cash at bank and in hand 4,119 555
57,760 42,964
Creditors: amounts falling due within one year 5 (56,851) (42,309)
Net current assets 909 655
Net assets 909 655
Capital and reserves
Called up share capital 8 8
Profit and loss account 901 647
Shareholders' funds 909 655
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Dr F Wernig
Director
Approved by the board on 29 July 2024
Endocrine1 Ltd
Notes to the Accounts
for the year ended 31 July 2023
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover represents the fair value of the consideration received or receivable for services provided, net of discounts and value added taxes.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Plant and machinery over 3 years
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
2 Employees 2023 2022
Number Number
Average number of persons employed by the company 1 1
3 Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 August 2022 2,327
At 31 July 2023 2,327
Depreciation
At 1 August 2022 2,327
At 31 July 2023 2,327
Net book value
At 31 July 2023 -
4 Debtors 2023 2022
£ £
Trade debtors 22,503 30,260
Other debtors 31,138 12,149
53,641 42,409
5 Creditors: amounts falling due within one year 2023 2022
£ £
Taxation and social security costs 50,838 37,170
Other creditors 6,013 5,139
56,851 42,309
6 Loans to directors
Description and conditions B/fwd Paid Repaid C/fwd
£ £ £ £
Dr F Wernig & Dr C Schurr
Joint directors' loan account that is interest free and repayable on demand 10,228 118,012 (97,102) 31,138
10,228 118,012 (97,102) 31,138
7 Other information
Endocrine1 Ltd is a private company limited by shares and incorporated in England. Its registered office is:
31 Trott Street
London
SW11 3DS
Endocrine1 Ltd 08131565 false 2022-08-01 2023-07-31 2023-07-31 VT Final Accounts October 2023 release 2 Dr F Wernig No description of principal activity 08131565 2021-08-01 2022-07-31 08131565 core:WithinOneYear 2022-07-31 08131565 core:ShareCapital 2022-07-31 08131565 core:RetainedEarningsAccumulatedLosses 2022-07-31 08131565 2022-08-01 2023-07-31 08131565 bus:PrivateLimitedCompanyLtd 2022-08-01 2023-07-31 08131565 bus:AuditExemptWithAccountantsReport 2022-08-01 2023-07-31 08131565 bus:Director40 2022-08-01 2023-07-31 08131565 1 2022-08-01 2023-07-31 08131565 2 2022-08-01 2023-07-31 08131565 bus:Director3 2022-08-01 2023-07-31 08131565 bus:Director3 1 2022-08-01 2023-07-31 08131565 countries:England 2022-08-01 2023-07-31 08131565 bus:FRS102 2022-08-01 2023-07-31 08131565 bus:FullAccounts 2022-08-01 2023-07-31 08131565 2023-07-31 08131565 core:WithinOneYear 2023-07-31 08131565 core:ShareCapital 2023-07-31 08131565 core:RetainedEarningsAccumulatedLosses 2023-07-31 08131565 core:PlantMachinery 2023-07-31 08131565 bus:Director3 1 2023-07-31 08131565 2022-07-31 08131565 core:PlantMachinery 2022-07-31 08131565 bus:Director3 1 2022-07-31 iso4217:GBP xbrli:pure